Project Owner | | Project City | State | Years | Value | Winstanley Enterprises LLC | New Haven Grassroot Life Science R&D Building | New Haven | CT | 2021-23 | $100 million |
Alexion Pharmaceuticals Incorporated | New Haven Biopharmaceutical Research & Development Plant Expansion | New Haven | CT | 2022-24 | $50 million |
BioLabs LLC New Haven | New Haven Brownfield Biolabs Incubator Space R&D | New Haven | CT | 2023-24 | $20 million |
Cure Rare Disease Incorporated | Woodbridge Brownfield Neuromuscular Gene Therapy Crdmo Laboratory Addition | Woodbridge | CT | 2023 | $15 million |
Alexion Pharmaceuticals Incorporated | New Haven Biopharmaceutical R&D Laboratory Renovatio | New Haven | CT | 2020 | $10 million |
Pfizer Incorporated | Groton Clinical-Scale Cyclotrons Gmp R&D Laboratory Upgrades (Building 274) | Groton | CT | 2024-25 | $10 million |
Pfizer Incorporated | Groton Clinical Scale Gmp R&D Laboratory Renovation (Building 156) | Groton | CT | 2024-25 | $8 million |
Pfizer Incorporated | Groton Small Molecules Gmp R&D Laboratory Renovation (Building 257) | Groton | CT | 2024-25 | $8 million |
Halda Therapeutics | New Haven Brownfield Novel Therapeutics R&D Laboratory Tenant Fit-Out | New Haven | CT | 2020-21 | $7 million |
Boehringer Ingelheim Pharmaceuticals Inc. | Ridgefield Pharma Pilot-Scale R&D Center Critical Systems Upgrade | Ridgefield | CT | 2020-21 | $6 million |